Pluristem Therapeutics Inc. RESTRICTED STOCK UNITS AGREEMENT Made as of _______________Restricted Stock Units Agreement • September 13th, 2021 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 13th, 2021 Company IndustryWHEREAS on March 28, 2019, the Company duly adopted and the Compensation Committee approved the 2019 Equity Compensation Plan and on June 13, 2019, the Company’s stockholders approved the adoption of the 2019 Equity Compensation Plan, a copy of which has been made available to the Participant, forming an integral part hereof (the “Plan”); and –
Pluristem Therapeutics Inc. RESTRICTED STOCK UNITS AGREEMENT Made as of ______________Restricted Stock Units Agreement • September 13th, 2021 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 13th, 2021 Company IndustryWHEREAS on March 28, 2019, the Company, and the Compensation Committee, duly adopted and approved the 2019 Equity Compensation Plan and on June 13, 2019, the Company’s stockholders approved the adoption of the 2019 Equity Compensation Plan, a copy of which has been made available to the Optionee, forming an integral part hereof (the “Plan”); and –
AGREEMENTAgreement • September 13th, 2021 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 13th, 2021 Company IndustryThis CLARIFICATION TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) dated as of September 13, 2021, by and between Pluristem Ltd. (the “Company”) and Ms. Chen Franco-Yehuda (the “Executive”). Each of the Company and the Executive shall be referred to collectively as the “Parties” and individually as a “Party.”
AGREEMENTAgreement • September 13th, 2021 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 13th, 2021 Company IndustryThis CLARIFICATION TO AMENDED AND RESTATED CONSULTING AGREEMENT (this “Agreement”) dated as of September 13, 2021, by and between Pluristem Ltd. (the “Company”) and Rose High Tech Ltd. of Tel Mond, Israel (the “Consultant”). Each of the Company and the Consultant shall be referred to collectively as the “Parties” and individually as a “Party.”